AACR Annual Meeting 2023 AACR 2023: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable NSCLC
Graft-vs.-Host Disease Blood Urea Nitrogen-to-Albumin Ratio Predicts Mortality in Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
Leukemia Real-World Genomic Testing and Treatment Patterns for Adult Patients Newly Diagnosed With Leukemia
